Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash from Operations: 2009-2012

Historic Cash from Operations for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2012 value amounting to -$20.4 million.

  • Lexicon Pharmaceuticals' Cash from Operations rose 9.15% to -$20.4 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$94.5 million, marking a year-over-year decrease of 7.42%. This contributed to the annual value of -$178.8 million for FY2024, which is 10.43% down from last year.
  • According to the latest figures from Q4 2012, Lexicon Pharmaceuticals' Cash from Operations is -$20.4 million, which was up 18.50% from -$25.1 million recorded in Q3 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Cash from Operations registered a high of -$17.3 million during Q4 2009, and its lowest value of -$28.2 million during Q1 2009.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Cash from Operations value was -$21.8 million (recorded in 2010), while the average stood at -$22.1 million.
  • Per our database at Business Quant, Lexicon Pharmaceuticals' Cash from Operations climbed by 22.92% in 2010 and then fell by 25.36% in 2012.
  • Over the past 4 years, Lexicon Pharmaceuticals' Cash from Operations (Quarterly) stood at -$17.3 million in 2009, then declined by 12.53% to -$19.4 million in 2010, then dropped by 15.86% to -$22.5 million in 2011, then grew by 9.15% to -$20.4 million in 2012.
  • Its last three reported values are -$20.4 million in Q4 2012, -$25.1 million for Q3 2012, and -$22.0 million during Q2 2012.